Natural Health Trends (NHTC) 10-Q 28 Jul 15 2015 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Jul. 21, 2015
Entity Registrant Name	NATURAL HEALTH TRENDS CORP
Entity Central Index Key	912,061
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		12,395,938
Document Type	10-Q
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q2
Amendment Flag	false

Consolidated Balance Sheets (Cu

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 74,422,000	$ 44,816,000
Accounts receivable	297,000	107,000
Inventories, net	5,287,000	3,760,000
Other current assets	1,643,000	930,000
Total current assets	81,649,000	49,613,000
Property and equipment, net	702,000	476,000
Goodwill	1,764,000	1,764,000
Restricted cash	3,591,000	315,000
Other assets	598,000	372,000
Total assets	88,304,000	52,540,000
Current liabilities:
Accounts payable	3,082,000	2,232,000
Income taxes payable	323,000	268,000
Accrued distributor commissions	14,338,000	8,853,000
Other accrued expenses	10,751,000	6,743,000
Deferred revenue	8,151,000	2,687,000
Deferred tax liability	65,000	65,000
Amounts held in distributor eWallets	8,533,000	2,064,000
Other current liabilities	1,696,000	1,513,000
Total current liabilities	46,939,000	24,425,000
Long-term incentive	1,524,000	1,665,000
Total liabilities	48,463,000	$ 26,090,000
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	0	$ 0
Common stock, $0.001 par value; 50,000,000 shares authorized; 12,891,317 and 12,979,414 shares issued at December 31, 2014 and June 30, 2015, respectively	13,000	13,000
Additional paid-in capital	85,928,000	85,750,000
Accumulated deficit	(36,549,000)	(54,799,000)
Accumulated other comprehensive income	135,000	62,000
Treasury stock, at cost; 384,220 and 583,476 shares at December 31, 2014 and June 30, 2015, respectively	(9,686,000)	(4,576,000)
Total stockholders’ equity	39,841,000	26,450,000
Total liabilities and stockholders’ equity	$ 88,304,000	$ 52,540,000

Consolidated Balance Sheets (C3

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Jun. 30, 2015	Dec. 31, 2014
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	12,979,414	12,891,317
Treasury stock, shares (in shares)	583,476	384,220

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - Scenario, Unspecified [Domain] - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Net sales	$ 69,716	$ 34,189	$ 110,425	$ 57,351
Cost of sales	14,094	7,509	23,024	12,761
Gross profit	55,622	26,680	87,401	44,590
Operating expenses:
Distributor commissions	35,010	15,458	53,407	25,881
Selling, general and administrative expenses (including stock-based compensation expense of $9 and $20 during the three months ended June 30, 2014 and 2015, respectively, and $34 and $35 during the six months ended June 30, 2014 and 2015, respectively)	8,281	5,031	14,704	9,378
Depreciation and amortization	68	23	109	44
Total operating expenses	43,359	20,512	68,220	35,303
Income from operations	12,263	6,168	19,181	9,287
Other income (expense), net	132	1	23	(8)
Income before income taxes	12,395	6,169	19,204	9,279
Income tax provision	122	59	193	98
Net income	$ 12,273	6,110	$ 19,011	9,181
Preferred stock dividends		(3)		(7)
Net income available to common stockholders	$ 12,273	$ 6,107	$ 19,011	$ 9,174
Income per common share:
Basic (in dollars per share)	$ 0.99	$ 0.51	$ 1.53	$ 0.78
Diluted (in dollars per share)	$ 0.98	$ 0.49	$ 1.52	$ 0.76
Weighted-average number of common shares outstanding:
Basic (in shares)	12,403	11,821	12,428	11,592
Diluted (in shares)	12,461	12,305	12,513	12,050
Cash dividends declared per share:
Common (in dollars per share)	$ 0.03	$ 0.005	$ 0.05	$ 0.01
Series A preferred stock (in dollars per share)		$ 0.02		$ 0.835

Consolidated Statements of Ope5

Consolidated Statements of Operations (Unaudited) (Parentheticals) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Stock-based compensation expense included in selling, general, and administrative expense	$ 20	$ 9	$ 35	$ 34

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Net income	$ 12,273	$ 6,110	$ 19,011	$ 9,181
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	16	$ 42	153	$ 15
Release of cumulative translation adjustment	(82)		(82)
Net change in foreign currency translation adjustment	(66)	$ 42	71	$ 15
Unrealized gains on available-for-sale securities	2		2
Comprehensive income	$ 12,209	$ 6,152	$ 19,084	$ 9,196

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 19,011,000	$ 9,181,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	109,000	44,000
Stock-based compensation	35,000	$ 34,000
Cumulative translation adjustment realized in net income	(82,000)
Changes in assets and liabilities:
Accounts receivable	(186,000)	$ 24,000
Inventories, net	(1,524,000)	(2,502,000)
Other current assets	(672,000)	(104,000)
Other assets	(232,000)	(16,000)
Accounts payable	849,000	1,586,000
Income taxes payable	56,000	86,000
Accrued distributor commissions	5,471,000	1,268,000
Other accrued expenses	4,674,000	2,466,000
Deferred revenue	5,459,000	$ 606,000
Amounts held in distributor eWallets	6,468,000
Other current liabilities	186,000	$ 152,000
Long-term incentive	(141,000)
Net cash provided by operating activities	39,481,000	$ 12,825,000
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment, net	(333,000)	$ (97,000)
Increase in restricted cash	(3,272,000)
Net cash used in investing activities	(3,605,000)	$ (97,000)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of warrants	309,000	2,630,000
Repurchase of common stock	(6,082,000)	(63,000)
Dividends paid	(621,000)	(195,000)
Net cash provided by (used in) financing activities	(6,394,000)	2,372,000
Effect of exchange rates on cash and cash equivalents	124,000	(28,000)
Net increase in cash and cash equivalents	29,606,000	15,072,000
CASH AND CASH EQUIVALENTS, beginning of period	44,816,000	14,550,000
CASH AND CASH EQUIVALENTS, end of period	$ 74,422,000	29,622,000
NON-CASH FINANCING ACTIVITY:
Conversion of preferred stock		29,000
Cash dividends declared, but not yet paid		$ 25,000
Issuance of treasury stock	$ 666,000

Note 1 - Nature of Operations a

Note 1 - Nature of Operations and Basis of Presentation	6 Months Ended
	Jun. 30, 2015
Notes to Financial Statements
Business Description and Basis of Presentation [Text Block]	1. NATURE OF OPERATIONS AND BASIS OF PRESENTATION Nature of Operations Natural Health Trends Corp. (the “Company”), a Delaware corporation, is an international direct-selling and e-commerce company headquartered in Dallas, Texas. Subsidiaries controlled by the Company sell personal care, wellness, and “quality of life” products under the “NHT Global” brand. In most markets, we sell our products to an independent member network that either uses the products themselves or resells them to consumers. Our wholly-owned subsidiaries have an active physical presence in the following markets: North America; Greater China, which consists of Hong Kong, Taiwan and China; South Korea; Japan; and Europe, which consists of Italy and Slovenia. We also operate within certain Commonwealth of Independent States (Russia and Kazakhstan) through our engagement with a local service provider. Basis of Presentation The unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. As a result, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information for the interim periods presented. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our 2014 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (SEC) on March 6, 2015.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2015
Notes to Financial Statements
Significant Accounting Policies [Text Block]	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The consolidated financial statements include the accounts of the Company and all of its wholly-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates associated with obsolete inventory and the fair value of acquired intangible assets, including goodwill, revenue recognition, as well as those used in the determination of liabilities related to sales returns, distributor commissions and income taxes. Various assumptions and other factors prompt the determination of these significant estimates. The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions. The actual results may differ materially and adversely from the Company’s estimates. To the extent that there are material differences between the estimates and actual results, future results of operations will be affected. Cash and Cash Equivalents As of June 30, 2015, cash and cash equivalents include $2.8 million held in banks located within China, which is subject to foreign currency controls. Additionally, as of June 30, 2015, cash and cash equivalents include the Company's investments in debt securities, comprising municipal notes and bonds. The Company considers all highly liquid investments with original maturities of three months or less when purchased and have insignificant interest rate risk to be cash equivalents. Debt securities classified as cash equivalents are required to be accounted for in accordance with ASC 320, Investments - Debt and Equity Securities Cash and cash equivalents at the end of each period were as follows (in thousands): December 31, 2014 June 30, 2015 Cash $ 37,314 $ 51,852 Available-for-sale investments 7,502 22,570 Total cash and cash equivalents $ 44,816 $ 74,422 Restricted Cash In June 2015, the Company funded a bank deposit account in the amount of CNY 20 million (USD 3.3 million) in anticipation of submitting a direct selling license application. Such deposit is required by Chinese laws to establish a consumer protection fund. Income Taxes The Company recognizes income taxes under the liability method of accounting for income taxes. Deferred income taxes are recognized for differences between the financial reporting and tax bases of assets and liabilities at enacted statutory tax rates in effect for the years in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense. Deferred taxes are not provided on the portion of undistributed earnings of subsidiaries outside of the United States when these earnings are considered permanently reinvested. The Company and its subsidiaries file income tax returns in the United States, various states, and foreign jurisdictions. The Company is no longer subject to U.S. federal income tax examinations for years prior to 2011, and is no longer subject to state income tax examinations for years prior to 2010. No jurisdictions are currently examining any income tax returns of the Company or its subsidiaries. Fair Value of Financial Instruments The carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value because of their short maturities. The carrying amount of the noncurrent restricted cash approximates fair value since, absent the restrictions, the underlying assets would be included in cash and cash equivalents. Accounting standards permit companies, at their option, to choose to measure many financial instruments and certain other items at fair value. The Company has elected to not fair value existing eligible items. Available-for-sale investments included in cash equivalents at the end of each period were as follows (in thousands): December 31, 2014 June 30, 2015 Adjusted Cost Gross Unrealized Gains Fair Value Adjusted Cost Gross Unrealized Gains Fair Value Municipal bonds and notes $ - $ - $ - $ 10,003 $ 2 $ 10,005 Financial institution instruments 7,502 - 7,502 12,565 - 12,565 Total available-for-sale investments $ 7,502 $ - $ 7,502 $ 22,568 $ 2 $ 22,570 Financial institution instruments include instruments issued or managed by financial institutions such as money market fund deposits and time deposits. Accumulated Other Comprehensive Income The changes in accumulated other comprehensive income by component for the first six months of 2015 were as follows (in thousands): Foreign Currency Translation Adjustment Unrealized Gains on Available-For-Sale Investments Total Balance, December 31, 2014 $ 62 $ - $ 62 Other comprehensive income before reclassifications 153 2 155 Amounts reclassified out of accumulated other comprehensive income (82 ) - (82 ) Balance, June 30, 2015 $ 133 $ 2 $ 135 Revenue Recognition Product sales are recorded when the products are shipped and title passes to independent distributors. Product sales to distributors are made pursuant to a distributor agreement that provides for transfer of both title and risk of loss upon our delivery to the carrier that completes delivery to the distributors, which is commonly referred to as “F.O.B. Shipping Point.” The Company primarily receives payment by credit card at the time distributors place orders. Amounts received for unshipped product are recorded as deferred revenue. The Company’s sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return. Actual product returns are recorded as a reduction to net sales. The Company estimates and accrues a reserve for product returns based on its return policies and historical experience. Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months. Enrollment packages provide distributors access to both a personalized marketing website and a business management system. No upfront costs are deferred as the amount is nominal. Shipping charges billed to distributors are included in net sales. Costs associated with shipments are included in cost of sales. Various taxes on the sale of products and enrollment packages to distributors are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority. Income Per Share Basic income per share for the three and six month periods ended June 30, 2014 were computed via the “two-class” method by dividing net income allocated to common stockholders by the weighted-average number of common shares outstanding during the periods. Net income available to common stockholders was allocated to both common stock and participating securities as if all of the income for the periods had been distributed. The Company’s Series A convertible preferred stock was a participating security due to its participation rights related to dividends declared by the Company. If dividends were distributed to common stockholders, the Company was also required to pay dividends to the holders of the preferred stock in an amount equal to the greater of (1) the amount of dividends then accrued and not previously paid on such shares of preferred stock or (2) the amount payable if dividends were distributed to the common stockholders on an as-converted basis. Diluted income per share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. The dilutive effect of non-vested restricted stock and warrants is reflected by application of the treasury stock method. Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized and the amount of tax benefit that would be recorded in additional paid-in capital when the award becomes deductible are assumed to be used to repurchase shares. For the three and six month periods ended June 30, 2014, the dilutive effect of the Company’s Series A convertible preferred stock was calculated using the more dilutive of the “two-class” method and the “if-converted” method, which assumes that the preferred stock was converted into common stock at the beginning of the period. The following table illustrates the computation of basic and diluted income per share for the periods indicated (in thousands, except per share data): Three Months Ended June 30, 2014 2015 Income (Numerator) Shares (Denominator) Per Share Amount Income (Numerator) Shares (Denominator) Per Share Amount Basic EPS: Net income available to common stockholders $ 6,107 $ 12,273 Less: undistributed earnings to participating securities (48 ) - Net income allocated to common stockholders 6,059 11,821 $ 0.51 12,273 12,403 $ 0.99 Effect of dilutive securities: Warrants to purchase common stock - 444 - 6 Non-vested restricted stock - 40 - 52 Plus: reallocation of undistributed earnings to participating securities 2 - Diluted EPS: Net income allocated to common stockholders plus assumed conversions $ 6,061 12,305 $ 0.49 $ 12,273 12,461 $ 0.98 Six Months Ended June 30, 2014 2015 Income (Numerator) Shares (Denominator) Per Share Amount Income (Numerator) Shares (Denominator) Per Share Amount Basic EPS: Net income available to common stockholders $ 9,174 $ 19,011 Less: undistributed earnings to participating securities (80 ) - Net income allocated to common stockholders 9,094 11,592 $ 0.78 19,011 12,428 $ 1.53 Effect of dilutive securities: Warrants to purchase common stock - 396 - 39 Non-vested restricted stock - 62 - 46 Plus: reallocation of undistributed earnings to participating securities 4 - Diluted EPS: Net income allocated to common stockholders plus assumed conversions $ 9,098 12,050 $ 0.76 $ 19,011 12,513 $ 1.52 Recently Issued and Adopted Accounting Pronouncements In May 2014, the FASB issued ASU No. 2014-09, Revenue From Contracts With Customers In July 2015, the FASB issued ASU No. 2015-11, Inventory: Simplifying the Measurement of Inventory Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

Note 3 - Stock-based Compensati

Note 3 - Stock-based Compensation	6 Months Ended
	Jun. 30, 2015
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	3. STOCK-BASED COMPENSATION Stock-based compensation expense totaled $9,000 and $20,000 for the three months ended June 30, 2014 and 2015, respectively, and $34,000 and $35,000 for the six months ended June 30, 2014 and 2015, respectively. No tax benefits were attributed to the stock-based compensation because a valuation allowance was maintained for substantially all net deferred tax assets. On January 20, 2015, the Company’s Board of Directors granted 60,960 shares of restricted common stock to certain employees and its outside directors for the purpose of further aligning their interest with those of its stockholders and, as to the employee shares, settling fiscal 2014 performance incentives. The shares vest on a quarterly basis over the next three years and are subject to forfeiture in the event of their termination of service to the Company under specified circumstances. On February 11, 2015, the Board of Directors granted an additional 6,116 shares of restricted common stock subject to the same conditions. The following table summarizes the Company’s restricted stock activity: Shares Wtd. Avg. Price at Date of Issuance Nonvested at December 31, 2014 - $ - Granted 67,076 12.15 Vested (11,182 ) 12.15 Nonvested at June 30, 2015 55,894 12.15 As of June 30, 2015, total unrecognized stock-based compensation expense related to non-vested restricted stock was $128,000, which is expected to be recognized over a weighted-average period of 2.5 years. On August 13, 2012, the Board of Directors authorized the Company, acting as trustee for certain of its non-officer, overseas employees, to execute a Rule 10b5-1 plan to purchase 100,000 shares of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Exchange Act and the Company's policies regarding stock transactions. Pursuant to this authority, the Company, as Trustee, entered into a 10b5-1 plan and began purchasing in December 2012. The latest 10b5-1 plan terminated in November 2014, and the Company, as Trustee, has not entered into a new 10b5-1 plan. The employees will receive the stock as incentive compensation in quarterly increments over three years beginning March 15, 2013, provided that they are employees of the Company on the date of the distribution. Any common stock that is forfeited by an employee whose employment terminates will be delivered to the Company and held as treasury stock. Shares Wtd. Avg. Grant-Date Fair Value Nonvested at December 31, 2014 23,984 $ 1.37 Vested (12,004 ) 1.37 Nonvested at June 30, 2015 11,980 1.37 As of June 30, 2015, total unrecognized stock-based compensation expense related to these stock awards $14,000, which is expected to be recognized over a weighted-average period of 0.5 years.

Note 4 - Stockholders' Equity

Note 4 - Stockholders' Equity	6 Months Ended
	Jun. 30, 2015
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	4. STOCKHOLDERS’ EQUITY Dividends On February 27, 2015, the Board of Directors declared a cash dividend of $0.02 on each share of common stock outstanding, payable on March 27, 2015 to stockholders of record on March 17, 2015. On May 4, 2015, the Board of Directors declared a cash dividend of $0.03 on each share of common stock outstanding, payable on May 29, 2015 to stockholders of record on May 19, 2015. Treasury Stock On January 22, 2015, the Company entered into a Stock Repurchase Agreement with George K. Broady, a director of the Company and owner of more than 5% of its outstanding common stock. The agreement provided for the Company’s purchase from Mr. Broady in off-the-market, private transactions of a total of 91,817 shares of the Company’s common stock, which would be purchased at the rate of 5,000 shares each trading day following the date of the agreement until all of such shares were purchased (see Note 6). The shares would be purchased at a per share price equal to the closing price per share of the Company’s common stock on the preceding trading day, as reported on the primary market in which the Company’s common stock is publicly traded. The Company’s purchases concluded on February 19, 2015, and resulted in an aggregate purchase price of $1.1 million. On May 4, 2015, the Board of Directors approved a stock repurchase program of up to $5.0 million of the Company’s outstanding shares of common stock. In connection therewith, the Company was advised by Mr. Broady that he would participate in the stock repurchase program on a basis roughly proportional to his ownership interest (see Note 6). As such, the Company authorized its broker to proceed with the purchase of shares of the Company’s common stock in the open market for a total purchase price of $3.5 million in accordance with Rules 10b5-1 and 10b-18 under the Exchange Act. The open market repurchases were completed on May 12, 2015. The stock repurchase program, which included both open market purchases and the purchase of shares from Mr. Broady, resulted in the Company purchasing a total of 186,519 shares of its common stock for an aggregate purchase price of $5.0 million, plus transaction costs. Common Stock Purchase Warrants In April 2015, warrants to purchase 88,097 shares of common stock were exercised at $3.5043 per share for total proceeds of $309,000.

Note 5 - Contingencies

Note 5 - Contingencies	6 Months Ended
	Jun. 30, 2015
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	5. CONTINGENCIES As required by the Door-to-Door Sales Act in South Korea, the Company maintains insurance for consumer indemnity claims with a mutual aid cooperative by possessing a mutual aid contract with Mutual Aid Cooperative & Consumer (the “Cooperative”). The contract secures payment to distributors in the event that the Company is unable to provide refunds to distributors. Typically, requests for refunds are paid directly by the Company according to the Company’s normal Korean refund policy, which requires that refund requests be submitted within three months. Accordingly, the Company estimates and accrues a reserve for product returns based on this policy and its historical experience. Depending on the sales volume, the Company may be required to increase or decrease the amount of the contract. The maximum potential amount of future payments the Company could be required to make to address actual distributor claims under the contract is equivalent to three months of rolling sales. At June 30, 2015, non-current other assets include KRW 223 million (USD $198,000) underlying the contract, which can be utilized by the Cooperative to fund any outstanding distributor claims. The Company believes that the likelihood of utilizing these funds to provide for distributors claims is remote.

Note 6- Related Party Transacti

Note 6- Related Party Transactions	6 Months Ended
	Jun. 30, 2015
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	6. RELATED PARTY TRANSACTIONS Product Royalties In February 2013, the Company entered into a Royalty Agreement and License with Broady Health Sciences, L.L.C., a Texas limited liability company, (“BHS”) regarding the manufacture and sale of a product called ReStor™. Also, on April 29, 2015, the Company entered into a Royalty Agreement and License with BHS regarding the manufacture and sale of a product called Soothe Stock Repurchase Agreements On January 22, 2015, the Company entered into a Stock Repurchase Agreement with George K. Broady, a director of the Company and owner of more than 5% of its outstanding common stock. The agreement provided for the Company’s purchase from Mr. Broady in off-the-market, private transactions of a total of 91,817 shares of the Company’s common stock, which would be purchased at the rate of 5,000 shares each trading day following the date of the agreement until all of such shares were purchased. The shares would be purchased at a per share price equal to the closing price per share of the Company’s common stock on the preceding trading day, as reported on the primary market in which the Company’s common stock is publicly traded. The Company’s purchases concluded on February 19, 2015, and resulted in an aggregate purchase price of $1.1 million. See Note 4. On May 7, 2015, the Company entered into a Stock Repurchase Agreement with Mr. Broady that provided for the Company’s purchase of common stock from Mr. Broady in off-the-market, private transactions at a rate equal to 0.4286 times the number of shares purchased by the Company’s broker in conjunction with the stock repurchase program authorized by the Company’s Board of Directors on May 4, 2015. The Company’s purchases from Mr. Broady concluded on May 13, 2015, and resulted in an aggregate purchase price of $1.5 million. See Note 4.

Note 7 - Subsequent Events

Note 7 - Subsequent Events	6 Months Ended
	Jun. 30, 2015
Notes to Financial Statements
Subsequent Events [Text Block]	7. SUBSEQUENT EVENTS On July 28, 2015, the Board of Directors declared a cash dividend of $0.04 on each share of common stock outstanding. Such dividends are payable on August 28, 2015 to stockholders of record on August 18, 2015. Payment of any future dividends on shares of common stock will be at the discretion of the Company’s Board of Directors. Also on July 28, 2015, the Board of Directors approved a stock repurchase program of up to $15.0 million of the Company’s outstanding shares of common stock, including $5.0 million of repurchases intended to be executed as soon as possible. Such repurchases are expected to be executed to the extent that the Company’s earnings and cash-on-hand allow, and are anticipated to be conducted through December 2016. Such repurchases will be made in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934 (the “Exchange Act”). For all or a portion of the authorized repurchase amount, the Company may enter into one or more plans that are compliant with Rule 10b5-1 of the Exchange Act that are designed to facilitate these purchases. The repurchase program does not require the Company to acquire a specific number of shares, and may be suspended from time to time or discontinued. The Company anticipates that George K. Broady, its largest shareholder and a member of its Board of Directors, will participate in the Company’s repurchase program on a basis roughly proportional to his ownership interest. To that end, the Company and Mr. Broady are in discussions regarding the terms of a mutually agreeable stock purchase agreement.

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The consolidated financial statements include the accounts of the Company and all of its wholly-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates associated with obsolete inventory and the fair value of acquired intangible assets, including goodwill, revenue recognition, as well as those used in the determination of liabilities related to sales returns, distributor commissions and income taxes. Various assumptions and other factors prompt the determination of these significant estimates. The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions. The actual results may differ materially and adversely from the Company’s estimates. To the extent that there are material differences between the estimates and actual results, future results of operations will be affected.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents As of June 30, 2015, cash and cash equivalents include $2.8 million held in banks located within China, which is subject to foreign currency controls. Additionally, as of June 30, 2015, cash and cash equivalents include the Company's investments in debt securities, comprising municipal notes and bonds. The Company considers all highly liquid investments with original maturities of three months or less when purchased and have insignificant interest rate risk to be cash equivalents. Debt securities classified as cash equivalents are required to be accounted for in accordance with ASC 320, Investments - Debt and Equity Securities Cash and cash equivalents at the end of each period were as follows (in thousands): December 31, 2014 June 30, 2015 Cash $ 37,314 $ 51,852 Available-for-sale investments 7,502 22,570 Total cash and cash equivalents $ 44,816 $ 74,422
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]	Restricted Cash In June 2015, the Company funded a bank deposit account in the amount of CNY 20 million (USD 3.3 million) in anticipation of submitting a direct selling license application. Such deposit is required by Chinese laws to establish a consumer protection fund.
Income Tax, Policy [Policy Text Block]	Income Taxes The Company recognizes income taxes under the liability method of accounting for income taxes. Deferred income taxes are recognized for differences between the financial reporting and tax bases of assets and liabilities at enacted statutory tax rates in effect for the years in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense. Deferred taxes are not provided on the portion of undistributed earnings of subsidiaries outside of the United States when these earnings are considered permanently reinvested. The Company and its subsidiaries file income tax returns in the United States, various states, and foreign jurisdictions. The Company is no longer subject to U.S. federal income tax examinations for years prior to 2011, and is no longer subject to state income tax examinations for years prior to 2010. No jurisdictions are currently examining any income tax returns of the Company or its subsidiaries.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments The carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value because of their short maturities. The carrying amount of the noncurrent restricted cash approximates fair value since, absent the restrictions, the underlying assets would be included in cash and cash equivalents. Accounting standards permit companies, at their option, to choose to measure many financial instruments and certain other items at fair value. The Company has elected to not fair value existing eligible items. Available-for-sale investments included in cash equivalents at the end of each period were as follows (in thousands): December 31, 2014 June 30, 2015 Adjusted Cost Gross Unrealized Gains Fair Value Adjusted Cost Gross Unrealized Gains Fair Value Municipal bonds and notes $ - $ - $ - $ 10,003 $ 2 $ 10,005 Financial institution instruments 7,502 - 7,502 12,565 - 12,565 Total available-for-sale investments $ 7,502 $ - $ 7,502 $ 22,568 $ 2 $ 22,570 Financial institution instruments include instruments issued or managed by financial institutions such as money market fund deposits and time deposits.
Comprehensive Income, Policy [Policy Text Block]	Accumulated Other Comprehensive Income The changes in accumulated other comprehensive income by component for the first six months of 2015 were as follows (in thousands): Foreign Currency Translation Adjustment Unrealized Gains on Available-For-Sale Investments Total Balance, December 31, 2014 $ 62 $ - $ 62 Other comprehensive income before reclassifications 153 2 155 Amounts reclassified out of accumulated other comprehensive income (82 ) - (82 ) Balance, June 30, 2015 $ 133 $ 2 $ 135
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition Product sales are recorded when the products are shipped and title passes to independent distributors. Product sales to distributors are made pursuant to a distributor agreement that provides for transfer of both title and risk of loss upon our delivery to the carrier that completes delivery to the distributors, which is commonly referred to as “F.O.B. Shipping Point.” The Company primarily receives payment by credit card at the time distributors place orders. Amounts received for unshipped product are recorded as deferred revenue. The Company’s sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return. Actual product returns are recorded as a reduction to net sales. The Company estimates and accrues a reserve for product returns based on its return policies and historical experience. Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months. Enrollment packages provide distributors access to both a personalized marketing website and a business management system. No upfront costs are deferred as the amount is nominal. Shipping charges billed to distributors are included in net sales. Costs associated with shipments are included in cost of sales. Various taxes on the sale of products and enrollment packages to distributors are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority.
Earnings Per Share, Policy [Policy Text Block]	Income Per Share Basic income per share for the three and six month periods ended June 30, 2014 were computed via the “two-class” method by dividing net income allocated to common stockholders by the weighted-average number of common shares outstanding during the periods. Net income available to common stockholders was allocated to both common stock and participating securities as if all of the income for the periods had been distributed. The Company’s Series A convertible preferred stock was a participating security due to its participation rights related to dividends declared by the Company. If dividends were distributed to common stockholders, the Company was also required to pay dividends to the holders of the preferred stock in an amount equal to the greater of (1) the amount of dividends then accrued and not previously paid on such shares of preferred stock or (2) the amount payable if dividends were distributed to the common stockholders on an as-converted basis. Diluted income per share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. The dilutive effect of non-vested restricted stock and warrants is reflected by application of the treasury stock method. Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized and the amount of tax benefit that would be recorded in additional paid-in capital when the award becomes deductible are assumed to be used to repurchase shares. For the three and six month periods ended June 30, 2014, the dilutive effect of the Company’s Series A convertible preferred stock was calculated using the more dilutive of the “two-class” method and the “if-converted” method, which assumes that the preferred stock was converted into common stock at the beginning of the period. The following table illustrates the computation of basic and diluted income per share for the periods indicated (in thousands, except per share data): Three Months Ended June 30, 2014 2015 Income (Numerator) Shares (Denominator) Per Share Amount Income (Numerator) Shares (Denominator) Per Share Amount Basic EPS: Net income available to common stockholders $ 6,107 $ 12,273 Less: undistributed earnings to participating securities (48 ) - Net income allocated to common stockholders 6,059 11,821 $ 0.51 12,273 12,403 $ 0.99 Effect of dilutive securities: Warrants to purchase common stock - 444 - 6 Non-vested restricted stock - 40 - 52 Plus: reallocation of undistributed earnings to participating securities 2 - Diluted EPS: Net income allocated to common stockholders plus assumed conversions $ 6,061 12,305 $ 0.49 $ 12,273 12,461 $ 0.98 Six Months Ended June 30, 2014 2015 Income (Numerator) Shares (Denominator) Per Share Amount Income (Numerator) Shares (Denominator) Per Share Amount Basic EPS: Net income available to common stockholders $ 9,174 $ 19,011 Less: undistributed earnings to participating securities (80 ) - Net income allocated to common stockholders 9,094 11,592 $ 0.78 19,011 12,428 $ 1.53 Effect of dilutive securities: Warrants to purchase common stock - 396 - 39 Non-vested restricted stock - 62 - 46 Plus: reallocation of undistributed earnings to participating securities 4 - Diluted EPS: Net income allocated to common stockholders plus assumed conversions $ 9,098 12,050 $ 0.76 $ 19,011 12,513 $ 1.52
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued and Adopted Accounting Pronouncements In May 2014, the FASB issued ASU No. 2014-09, Revenue From Contracts With Customers In July 2015, the FASB issued ASU No. 2015-11, Inventory: Simplifying the Measurement of Inventory Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

Note 2 - Summary of Significa16

Note 2 - Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2015
Notes Tables
Schedule of Cash and Cash Equivalents [Table Text Block]	December 31, 2014 June 30, 2015 Cash $ 37,314 $ 51,852 Available-for-sale investments 7,502 22,570 Total cash and cash equivalents $ 44,816 $ 74,422
Available-for-sale Securities [Table Text Block]	December 31, 2014 June 30, 2015 Adjusted Cost Gross Unrealized Gains Fair Value Adjusted Cost Gross Unrealized Gains Fair Value Municipal bonds and notes $ - $ - $ - $ 10,003 $ 2 $ 10,005 Financial institution instruments 7,502 - 7,502 12,565 - 12,565 Total available-for-sale investments $ 7,502 $ - $ 7,502 $ 22,568 $ 2 $ 22,570
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Foreign Currency Translation Adjustment Unrealized Gains on Available-For-Sale Investments Total Balance, December 31, 2014 $ 62 $ - $ 62 Other comprehensive income before reclassifications 153 2 155 Amounts reclassified out of accumulated other comprehensive income (82 ) - (82 ) Balance, June 30, 2015 $ 133 $ 2 $ 135
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended June 30, 2014 2015 Income (Numerator) Shares (Denominator) Per Share Amount Income (Numerator) Shares (Denominator) Per Share Amount Basic EPS: Net income available to common stockholders $ 6,107 $ 12,273 Less: undistributed earnings to participating securities (48 ) - Net income allocated to common stockholders 6,059 11,821 $ 0.51 12,273 12,403 $ 0.99 Effect of dilutive securities: Warrants to purchase common stock - 444 - 6 Non-vested restricted stock - 40 - 52 Plus: reallocation of undistributed earnings to participating securities 2 - Diluted EPS: Net income allocated to common stockholders plus assumed conversions $ 6,061 12,305 $ 0.49 $ 12,273 12,461 $ 0.98 Six Months Ended June 30, 2014 2015 Income (Numerator) Shares (Denominator) Per Share Amount Income (Numerator) Shares (Denominator) Per Share Amount Basic EPS: Net income available to common stockholders $ 9,174 $ 19,011 Less: undistributed earnings to participating securities (80 ) - Net income allocated to common stockholders 9,094 11,592 $ 0.78 19,011 12,428 $ 1.53 Effect of dilutive securities: Warrants to purchase common stock - 396 - 39 Non-vested restricted stock - 62 - 46 Plus: reallocation of undistributed earnings to participating securities 4 - Diluted EPS: Net income allocated to common stockholders plus assumed conversions $ 9,098 12,050 $ 0.76 $ 19,011 12,513 $ 1.52

Note 3 - Stock-based Compensa17

Note 3 - Stock-based Compensation (Tables)	6 Months Ended
	Jun. 30, 2015
Notes Tables
Nonvested Restricted Stock Shares Activity [Table Text Block]	Shares Wtd. Avg. Price at Date of Issuance Nonvested at December 31, 2014 - $ - Granted 67,076 12.15 Vested (11,182 ) 12.15 Nonvested at June 30, 2015 55,894 12.15
Schedule of Nonvested Share Activity [Table Text Block]	Shares Wtd. Avg. Grant-Date Fair Value Nonvested at December 31, 2014 23,984 $ 1.37 Vested (12,004 ) 1.37 Nonvested at June 30, 2015 11,980 1.37

Note 2 - Summary of Significa18

Note 2 - Summary of Significant Accounting Policies (Details Textual) $ in Thousands, ¥ in Millions	Jun. 30, 2015USD ($)	Jun. 30, 2015CNY (¥)	Dec. 31, 2014USD ($)	Jun. 30, 2014USD ($)	Dec. 31, 2013USD ($)
CHINA
Cash and Cash Equivalents, at Carrying Value	$ 2,800
Bank Deposit in Anticipation of Submitting Direct Selling License Application [Member]
Restricted Cash and Cash Equivalents	3,300	¥ 20
Cash and Cash Equivalents, at Carrying Value	$ 74,422		$ 44,816	$ 29,622	$ 14,550

Note 2 - Cash and Cash Equivale

Note 2 - Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Cash [Member]
Cash and cash equivalents	$ 51,852	$ 37,314
Available-for-Sale Investments[ Member]
Cash and cash equivalents	22,570	7,502
Cash and cash equivalents	$ 74,422	$ 44,816

Note 2 - Available-for-sale Inv

Note 2 - Available-for-sale Investments (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Municipal Bonds and Notes [Member]
Adjusted cost	$ 10,003
Gross unrealized gains	2
Fair value	10,005
Financial Institution Instruments [Member]
Adjusted cost	$ 12,565	$ 7,502
Gross unrealized gains
Fair value	$ 12,565	$ 7,502
Adjusted cost	22,568	$ 7,502
Gross unrealized gains	2
Fair value	$ 22,570	$ 7,502

Note 2 - Changes in Accumulated

Note 2 - Changes in Accumulated Other Comprehensive Income (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2015USD ($)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Balance, December 31, 2014	$ 62
Other comprehensive income before reclassifications	153
Amounts reclassified out of accumulated other comprehensive income	(82)
Balance, June 30, 2015	$ 133
Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]
Balance, December 31, 2014
Other comprehensive income before reclassifications	$ 2
Amounts reclassified out of accumulated other comprehensive income
Balance, June 30, 2015	$ 2
Balance, December 31, 2014	62
Other comprehensive income before reclassifications	155
Amounts reclassified out of accumulated other comprehensive income	(82)
Balance, June 30, 2015	$ 135

Note 2 - Basic and Diluted Inco

Note 2 - Basic and Diluted Income Per Share (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Distributed [Member]
Basic EPS:
Net income available to common stockholders	$ 12,273	$ 6,059	$ 19,011	$ 9,094
Net income allocated to common stockholders (in shares)	12,403	11,821	12,428	11,592
Net income allocated to common stockholders (in dollars per share)	$ 0.99	$ 0.51	$ 1.53	$ 0.78
Restricted Stock [Member]
Effect of dilutive securities:
Non-vested restricted stock (in shares)	52	40	46	62
Net income available to common stockholders	$ 12,273	$ 6,107	$ 19,011	$ 9,174
Less: undistributed earnings to participating securities		$ (48)		$ (80)
Net income allocated to common stockholders (in shares)	12,403	11,821	12,428	11,592
Net income allocated to common stockholders (in dollars per share)	$ 0.99	$ 0.51	$ 1.53	$ 0.78
Warrants to purchase common stock (in shares)	6	444	39	396
Plus: reallocation of undistributed earnings to participating securities		$ 2		$ 4
Diluted EPS:
Net income allocated to common stockholders plus assumed conversions	$ 12,273	$ 6,061	$ 19,011	$ 9,098
Net income allocated to common stockholders plus assumed conversions (in shares)	12,461	12,305	12,513	12,050
Net income allocated to common stockholders plus assumed conversions (in dollars per share)	$ 0.98	$ 0.49	$ 1.52	$ 0.76

Note 3 - Stock-based Compensa23

Note 3 - Stock-based Compensation (Details Textual) - USD ($)	Feb. 11, 2015	Jan. 20, 2015	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2013	Aug. 13, 2012
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	6,116	60,960			67,076
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		3 years
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 128,000		$ 128,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition					2 years 182 days
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense					$ 0
Allocated Share-based Compensation Expense			20,000	$ 9,000	35,000	$ 34,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 14,000		$ 14,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition					182 days
Stock Repurchase Program, Number of Shares Authorized to be Repurchased								100,000
Share-based Compensation Incentive Compensation Period							3 years

Note 3 - Stock-based Compensa24

Note 3 - Stock-based Compensation - Restricted Stock Activity (Details) - Restricted Stock [Member] - $ / shares	6 Months Ended
	Jun. 30, 2015
Nonvested (in shares)
Nonvested (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	67,076
Granted (in dollars per share)	$ 12.15
Vested (in shares)	(11,182)
Vested (in dollars per share)	$ 12.15
Nonvested (in shares)	55,894
Nonvested (in dollars per share)	$ 12.15

Note 3 - Stock-based Compensa25

Note 3 - Stock-based Compensation - Common Stock Unit Activity (Details) - 6 months ended Jun. 30, 2015 - $ / shares	Total
Nonvested (in shares)	23,984
Nonvested (in dollars per share)	$ 1.37
Vested (in shares)	(12,004)
Vested (in dollars per share)	$ 1.37
Nonvested at June 30, 2015 (in shares)	11,980
Nonvested at June 30, 2015 (in dollars per share)	$ 1.37

Note 4 - Stockholders' Equity (

Note 4 - Stockholders' Equity (Details Textual) - USD ($)	May. 13, 2015	May. 12, 2015	May. 04, 2015	Feb. 27, 2015	Feb. 19, 2015	Apr. 30, 2015	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Jan. 22, 2015
George K. Broady [Member]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners											5.00%
Treasury Stock, Shares, Acquired					91,817
Stock Repurchase Program, Number of Shares Repurchased Per Day					5,000
Treasury Stock, Value, Acquired, Cost Method	$ 1,500,000				$ 1,100,000
Common Stock, Dividends, Per Share, Declared			$ 0.03	$ 0.02			$ 0.03	$ 0.005	$ 0.05	$ 0.01
Treasury Stock, Shares, Acquired		186,519
Treasury Stock, Value, Acquired, Cost Method		$ 5,000,000
Stock Repurchase Program, Authorized Amount			$ 5,000,000
Treasury Stock, Value, Acquired, Cost Method, Excluding Related Party		$ 3,500,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						88,097
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 3.5043
Proceeds from Warrant Exercises						$ 309,000			$ 309,000	$ 2,630,000

Note 5 - Contingencies (Details

Note 5 - Contingencies (Details Textual) - Jun. 30, 2015 ₩ in Millions	KRW (₩)	USD ($)
Other Noncurrent Assets [Member]
Distributor Claims Reserve	₩ 223	$ 198,000

Note 6- Related Party Transac28

Note 6- Related Party Transactions (Details Textual)	May. 13, 2015USD ($)	May. 12, 2015USD ($)shares	Apr. 29, 2015	Feb. 19, 2015USD ($)shares	Feb. 28, 2013	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)	Dec. 31, 2014USD ($)	Jan. 22, 2015
Broady Health Sciences [Member] | Soothe [Member]
Royalty Rate			2.50%
Royalty Expense						$ 1,500	$ 1,400	$ 3,900	$ 3,200	$ 11,700
Number of Days Termination Notice			120 days
Broady Health Sciences [Member] | ReStore [Member]
Royalty Rate					2.50%
Royalty Expense						$ 144,000	$ 36,000	$ 256,000	$ 65,000
Number of Days Termination Notice					120 days
George Broady Member
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners					5.00%
George K. Broady [Member]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners											5.00%
Treasury Stock, Shares, Acquired | shares				91,817
Stock Repurchase Program, Number of Shares Repurchased Per Day | shares				5,000
Treasury Stock, Value, Acquired, Cost Method	$ 1,500,000			$ 1,100,000
Treasury Stock Acquired Rate	0.4286
Treasury Stock, Shares, Acquired | shares		186,519
Treasury Stock, Value, Acquired, Cost Method		$ 5,000,000

Note 7 - Subsequent Events (Det

Note 7 - Subsequent Events (Details Textual) - USD ($)	Jul. 28, 2015	May. 12, 2015	May. 04, 2015	Feb. 27, 2015	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Subsequent Event [Member]
Common Stock, Dividends, Per Share, Declared	$ 0.04
Stock Repurchase Program, Authorized Amount	$ 15,000,000
Treasury Stock, Value, Acquired, Cost Method	$ 5,000,000
Common Stock, Dividends, Per Share, Declared			$ 0.03	$ 0.02	$ 0.03	$ 0.005	$ 0.05	$ 0.01
Stock Repurchase Program, Authorized Amount			$ 5,000,000
Treasury Stock, Value, Acquired, Cost Method		$ 5,000,000